☰

Medidata Solutions Achieves 26th Quarter of Consecutive Growth


    Medidata Solutions, a global leader in electronic data capture
    (EDC), management and reporting solutions, today announced the
    company's 26th quarter of consecutive growth. Medidata completed the
    quarter with an 81.5 percent year over year revenue growth, signing 13
    new customers in the U.S., Europe and Japan and 15 follow-on contracts
    from existing customers.

    Nine of Medidata's 13 new customers this quarter were due to the
    success of its ASPire to Win partner program, which enables contract
    research organizations (CROs) to meet sponsor demand for Medidata
    Rave(R) and offer the platform in-house by building and deploying
    studies with Rave certified resources. Additionally, 17 new trials
    were initiated through existing ASPire to Win partners in the second
    quarter alone. During Q2, Medidata entered into a new ASPire to Win
    partnership with Chiltern Ltd to implement Medidata Rave to manage
    electronic clinical trial data for pharmaceutical and biotechnology
    sponsors around the world.

    Additional highlights from Q2 include:

    -- Growing European presence with H. Lundbeck A/S' selection of
    Medidata Rave as its EDC, management and reporting solution to
    manage several Phase II-IV trials with the goal of conducting
    10 or more studies in Rave each year;

    -- Growth in biotech with the implementation of Medidata Rave
    with California-based BioMarin Pharmaceutical;

    -- Continued relationships with pharmaceutical companies Sucampo
    Pharmaceuticals, Inc. and SuperGen, Inc;

    -- Strategic technology partnership with SAS, integrating
    Medidata Rave with SAS Drug Development to enable data
    streamlined access to study data on one uniform,
    regulatory-compliant data management path.

    In order to meet increased customer demand in 2007, Medidata
    Solutions increased its staff 29 percent across R&D, services, sales
    and strategic alliances and corporate areas throughout the U.S.,
    Europe and Japan. Medidata's executives continued to drive industry
    thought-leadership through a range of efforts:

    -- United BioSource Corporation, Medidata and Tessella began the
    first in a series of six educational webinars, entitled
    "Enabling Adaptive Clinical Trials."

    -- Through partnering with Fast Track Systems, Medidata hosted a
    webinar on integrating trial design and EDC study build for
    participants.

    -- Medidata, invivodata and CDISC presented a DIA-sponsored
    webinar on ePRO and EDC integration prior to the DIA Annual
    Meeting.

    -- Vice President of Global Regulatory Affairs and Quality
    Assurance Earl Hulihan was honored at the DIA Annual Meeting
    with the DIA Founders Service Award, recognizing his lifelong
    contributions to medicine and regulatory science.

    -- Medidata executives delivered presentations at industry events
    in Q2 including 2007 CDISC European Interchange, 43rd Annual
    DIA Meeting, 23rd Annual SQA Meeting, EDC & Beyond, SMi's 2007
    Phase IV Conference, and ViB's 7th Annual e-Clinical Trials
    2007.

    "We're pleased to attribute our continued growth this quarter to a
    significant number of follow-on contracts with existing customers, new
    sponsor commitments to Medidata Rave, and additional clients brought
    on as a result of our partnerships with the industry's leading CROs,"
    said Tarek Sherif, CEO of Medidata Solutions. "Through our strategic
    addition of key global customers, partners and Medidata staff, we've
    greatly increased our market presence this quarter and look forward to
    further success through the second half of the year."

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
    biotechnology, medical device and research organizations maximize the
    value of their clinical research investments. Innovative process
    design, technology and services streamline clinical trials by
    providing early visibility to reliable clinical data - the lifeblood
    of every research organization. Working with companies and
    institutions both large and small, Medidata Solutions helps clinical
    researchers safely accelerate the process of bringing life-enhancing
    treatments to market - on six continents and in more than 80
    countries. Medidata Solutions brings significant value to its broad
    client base with deep clinical experience and expertise in more than
    20 therapeutic areas, projects in Phase I, II, III, IV, registries and
    surveillance, and studies with thousands of investigators and
    tens-of-thousands of subjects. For more information, please visit
    www.mdsol.com.